7A24

ICD-11 MMS 2026-01

Hypersomnia due to a medication or substance

Description

Hypersomnia due to a medication or substance is characterised by excessive nocturnal sleep, daytime sleepiness, or excessive napping that is attributable to the sedating effects of medications, alcohol, or other psychoactive substances, including withdrawal syndromes (e.g., from stimulants) and is sufficiently severe to constitute an independent focus of clinical attention. Note: A definitive diagnosis requires use of polysomnography and multiple sleep latency test (MSLT) to rule out other hypersomnolence disorders or other sleep disorders (e.g. obstructive sleep apnea) which might better explain the sleepiness.

Index terms

  • Hypersomnia due to a medication or substance
  • Hypersomnia due to substances including medications
  • Hypersomnolence due to substances including medications

Inclusions

  • Hypersomnia due to substances including medications

Sibling codes

  • 7A20 – Narcolepsy
  • 7A21 – Idiopathic hypersomnia
  • 7A22 – Kleine-Levin syndrome
  • 7A23 – Hypersomnia due to a medical condition
  • 7A25 – Hypersomnia associated with a mental disorder
  • 7A26 – Insufficient sleep syndrome
  • 7A2Y – Other specified hypersomnolence disorders
  • 7A2Z – Hypersomnolence disorders, unspecified

Foundation entity

Hypersomnia due to a medication or substance – http://id.who.int/icd/entity/300740103

Allowed postcoordination axes

Part of: 07: Sleep-wake disorders